The results indicated that the AMPK/mTOR/ULK1/LC3B signaling pathway was involved in the anti-AD of GENI (Extended Data Figure S3c–f, Supplementary Figure S8). The gene discussed is MAP1LC3B; the disease is Alzheimer disease.